Sevelamer Carbonate for Oral Suspension missing lot and expiration date labels
Dr. Reddy's Laboratories is recalling Sevelamer Carbonate for Oral Suspension packets missing lot number and expiration date information. Approximately 5,136 cartons were distributed nationwide.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: FDA Class III recall for missing lot number and expiration date information on packets. This is a documentation and labeling issue with no reported safety hazard, product defect, or illnesses or injuries.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Sevelamer Carbonate for Oral Suspension in 0.8g packets due to missing lot number and expiration date information on the packet labels.
The affected lot is T2305999, which has an expiration date of November 2025. Approximately 5,136 cartons were distributed nationwide within the United States.
The packets lack printed lot numbers and expiration dates, which are required labeling elements for pharmaceutical products. This recall is classified by the FDA as Class III.
The recalled product
- Product
- SEVELAMER CARBONATE FOR ORAL SUSPENSION (SEVELAMER CARBONATE FOR ORAL SUSPENSION)
- Brand
- SEVELAMER CARBONATE FOR ORAL SUSPENSION
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug
- Hazard
- missing-lot-number
- missing-expiration-date
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: T2305999
- Exp. Date 11/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27